Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible

Chau Dang, Gabriella D'Andrea, Diana Lake, Steve Sugarman, Monica Fornier, Mary Ellen Moynahan, Theresa Gilewski, Arti Hurria, Nancy Mills, Tiffany Troso-Sandoval, Roshini George, Mark Robson, Maura Dickler, Karen Smith, Katherine Panageas, Larry Norton, Clifford Hudis

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible'. Together they form a unique fingerprint.

Medicine & Life Sciences